Tod Smeal - 10 Jan 2022 Form 3 Insider Report for Cardiff Oncology, Inc. (CRDF)

Role
Chief Scientific Officer
Signature
/s/ Tod Smeal
Issuer symbol
CRDF
Transactions as of
10 Jan 2022
Net transactions value
$0
Form type
3
Filing time
14 Jan 2022, 12:34:42 UTC
Next filing
16 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CRDF Stock Options 10 Jan 2022 Common Stock 275,088 $6.58 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 68,772 of the Options vest on January 10, 2023 and 5,731 vest monthly for 36 months beginning on February 10, 2023, provided the Optionee on the vesting date continues to provide services to the Company or an Affiliate.